TY - JOUR
T1 - Severe lympho-depletion, abrogated thymopoiesis and systemic EBV positive T-cell lymphoma of childhood, a case
AU - Asmussen, Anders
AU - Quintanilla-Martinez, Leticia
AU - Larsen, Martin
AU - Fagerberg, Christina
AU - Bækvad-Hansen, Marie
AU - Juul, Maja Bech
AU - Rewers, Kate
AU - Raaschou-Jensen, Klas
AU - Barnkob, Mike Bogetofte
AU - Møller, Michael Boe
AU - Assing, Kristian
PY - 2024/1
Y1 - 2024/1
N2 - Epstein-Barr virus (EBV) associated T-cell and NK-cell lymphoproliferative diseases are lethal and extremely rare in Caucasians. We expand on the clinical, immunological and histogenetic characteristics associated with this second European case (19 years old, previously healthy, Caucasian boy) of systemic EBV positive T-cell lymphoma of childhood. We report, as novel findings, severe lympho-depletion and abrogation of thymopoiesis secondary to severe EBV activation and excessive immune activation. Similar to the first European case, we also detected a somatic missense variant in the proto-oncogene FYN. In the first European patient however, the FYN variant allele frequency (VAF) was 10% and the patient only experienced moderate leukopenia, whereas in our case, the VAF was 48% and the patient experienced severe leukopenia and lymphopenia. This could suggest a pathogenic role of these FYN variants in driving excessive T cell activation. If confirmed, FYN might become target in future treatments of this fatal disorder.
AB - Epstein-Barr virus (EBV) associated T-cell and NK-cell lymphoproliferative diseases are lethal and extremely rare in Caucasians. We expand on the clinical, immunological and histogenetic characteristics associated with this second European case (19 years old, previously healthy, Caucasian boy) of systemic EBV positive T-cell lymphoma of childhood. We report, as novel findings, severe lympho-depletion and abrogation of thymopoiesis secondary to severe EBV activation and excessive immune activation. Similar to the first European case, we also detected a somatic missense variant in the proto-oncogene FYN. In the first European patient however, the FYN variant allele frequency (VAF) was 10% and the patient only experienced moderate leukopenia, whereas in our case, the VAF was 48% and the patient experienced severe leukopenia and lymphopenia. This could suggest a pathogenic role of these FYN variants in driving excessive T cell activation. If confirmed, FYN might become target in future treatments of this fatal disorder.
U2 - 10.1080/10428194.2023.2264425
DO - 10.1080/10428194.2023.2264425
M3 - Journal article
C2 - 37871127
SN - 1042-8194
VL - 65
SP - 118
EP - 122
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
IS - 1
ER -